N A Chung, G Y Lip, M Beevers, D G Beevers. Show Affiliations »
Abstract
Mesh: See more » Abnormalities, Drug-Induced/etiologyAbnormalities, Drug-Induced/prevention & controlAdultAngiotensin-Converting Enzyme Inhibitors/administration & dosageAngiotensin-Converting Enzyme Inhibitors/adverse effectsAntihypertensive Agents/adverse effectsFemaleHumansHypertension/diagnosisHypertension/drug therapyPregnancyPregnancy OutcomePregnancy Trimester, FirstPrenatal CareRisk AssessmentSensitivity and SpecificityTetrazoles/administration & dosageTetrazoles/adverse effectsTime FactorsValine/administration & dosageValine/adverse effectsValine/analogs & derivativesValsartan
Substances: See more » Angiotensin-Converting Enzyme InhibitorsAntihypertensive AgentsTetrazolesValsartanValine
Year: 2001 PMID: 11386316 DOI: 10.1016/S0140-6736(00)04759-0
Source DB: PubMed Journal: Lancet ISSN: 0140-6736 Impact factor: 79.321